We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The investigational injection SI-6603 may decrease pain ...
PARSIPPANY, N.J.--(BUSINESS WIRE)--Ferring Pharmaceuticals and its clinical development partner, Seikagaku Corporation (Seikagaku), today announced the presentation of data from two Phase 3 trials ...
The U.S. FDA’s Anesthetic and Analgesic Drug Products Advisory Committee will scrutinize Jan. 10 the safety and efficacy of Ferring Pharmaceuticals Inc.’s SI-6603 (condoliase), a chemonucleolytic drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results